Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine vs NPH Insulin in Type 2 Diabetes in Iran
NCT01832935Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2011
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Tehran University of Medical Sciences. Primary endpoint: Number of Hypoglycemic events at 12 months. Started Jul 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01832935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01832935.